CA2257234A1 - Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases - Google Patents
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseasesInfo
- Publication number
- CA2257234A1 CA2257234A1 CA002257234A CA2257234A CA2257234A1 CA 2257234 A1 CA2257234 A1 CA 2257234A1 CA 002257234 A CA002257234 A CA 002257234A CA 2257234 A CA2257234 A CA 2257234A CA 2257234 A1 CA2257234 A1 CA 2257234A1
- Authority
- CA
- Canada
- Prior art keywords
- disease
- diseases
- receptor
- treatment
- neurological disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
Method and compositions for treating a patient having a neurological disease or disorder, such as stroke, head trauma, spinal cord injury, spinal cord ischemia, ischemia- or hypoxia-induced nerve cell damage, epilepsy, anxiety, neuropsychiatric or cognitive deficits due to ischemia or hypoxia such as those that frequently occur as a consequence of cardiac surgery under cardiopulmonary bypass, or neurodegenerative diseases such as Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, or amyotrophic lateral sclerosis (ALS).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002560002A CA2560002A1 (en) | 1996-06-07 | 1996-12-11 | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66301396A | 1996-06-07 | 1996-06-07 | |
US08/663,013 | 1996-06-07 | ||
US9619525 | 1996-12-06 | ||
WOPCT/US96/19525 | 1996-12-06 | ||
PCT/US1996/020697 WO1997046511A1 (en) | 1996-06-07 | 1996-12-11 | Coumpounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002560002A Division CA2560002A1 (en) | 1996-06-07 | 1996-12-11 | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2257234A1 true CA2257234A1 (en) | 1997-12-11 |
CA2257234C CA2257234C (en) | 2007-01-16 |
Family
ID=26791398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002257234A Expired - Fee Related CA2257234C (en) | 1996-06-07 | 1996-12-11 | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2257234C (en) |
-
1996
- 1996-12-11 CA CA002257234A patent/CA2257234C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2257234C (en) | 2007-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1008980A1 (en) | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders | |
EP1123922A3 (en) | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases | |
CA2260037A1 (en) | Pharmaceutical compositions comprising s-(-)-n-propargyl-1-aminoindan | |
ATE294774T1 (en) | AMINOADAMANTAN DERIVATIVES AS THERAPEUTIC AGENTS | |
CA2244912A1 (en) | Novel substituted cyclic amino acids as pharmaceutical agents | |
CA2339273A1 (en) | Branched alkyl pyrrolidine-3-carboxylic acids | |
HUP9901629A2 (en) | Use of r(+)-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof | |
AU2001273574A1 (en) | Substituted 5-alkynyl pyrimidines having neurotrophic activity | |
HU9600959D0 (en) | Therapeutic agents | |
CA2257234A1 (en) | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases | |
MX9709911A (en) | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders. | |
AU3585089A (en) | Condensed diazepinones | |
EP0999204A4 (en) | Novel compound having effect of promoting neuron differentiation | |
EP0934934A3 (en) | Methods of preparing substituted 3-phenyl- and 3-pyridyl-4(3H)-quinazolinones and atropisomers thereof | |
EP0721778A3 (en) | NK-1 receptor antagonists for the treatment of neuronal injury and stroke | |
JO1833B1 (en) | Therapeutic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |